Market Overview

Trade RMED stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
5/14/20Piper SandlerMaintainsNeutral1.0
3/11/20Cantor FitzgeraldMaintainsNeutral1.5
8/13/19Piper JaffrayDowngradesOverweightNeutral1.5

Earnings View Earnings

Q1 2020 EST Actual Surprise
EPS: -0.340 -0.560 -0.2200
Rev: 1.58M 1.37M -206.00K
Q2 2020 EST Actual Surprise
EPS: Expected
2020-11-27
Rev:

Company Profile